Photodynamic treatment modulates various GTPase and cellular signalling pathways in Tauopathy

References

• Zhao J, Duan L, Wang A, et al. Insight into the efficiency of oxygen introduced photodynamic therapy (PDT) and deep PDT against cancers with various assembled nanocarriers. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:e1583.
   PubMed Web of Science ®Google Scholar
• Meimandi M, Ardakani MRT, Nejad AE, et al. The effect of photodynamic therapy in the treatment of chronic periodontitis: a review of literature. J Lasers Med Sci. 2017;8:S7.
   PubMed Web of Science ®Google Scholar
• Lan M, Zhao S, Liu W, et al. Photosensitizers for photodynamic therapy. Adv Healthc Mater. 2019;8:1900132.
   Web of Science ®Google Scholar
• Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2016;473:347–364.
   PubMed Web of Science ®Google Scholar
• Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250–281.
   PubMed Web of Science ®Google Scholar
• Kou J, Dou D, Yang L. Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget. 2017;8:81591.
   PubMedGoogle Scholar
• Kamkaew A, Lim SH, Lee HB, et al. BODIPY dyes in photodynamic therapy. Chem Soc Rev. 2013;42:77–88.
   PubMed Web of Science ®Google Scholar
• Ormond AB, Freeman HS. Dye sensitizers for photodynamic therapy. Materials. 2013;6:817–840.
   PubMed Web of Science ®Google Scholar
• Shi C, Wu JB, Pan D. Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy. J Biomed Opt. 2016;21:050901.
   PubMed Web of Science ®Google Scholar
• Li L, Chen Y, Chen W, et al. Photodynamic therapy based on organic small molecular fluorescent dyes. Chin Chem Lett. 2019;30:1689–1703.
   Web of Science ®Google Scholar
• Allison RR, Moghissi K. Photodynamic therapy (PDT): PDT mechanisms. Clin Endosc. 2013;46:24.
   PubMedGoogle Scholar
• Lawen A. Apoptosis—an introduction. Bioessays. 2003;25:888–896.
   PubMed Web of Science ®Google Scholar
• Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1–16.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang X, Zhang S, et al. Sinoporphyrin sodium, a novel sensitizer, triggers mitochondrial-dependent apoptosis in ECA-109 cells via production of reactive oxygen species. Int J Nanomedicine. 2014;9:3077.
   PubMed Web of Science ®Google Scholar
• Salmerón ML, Quintana‐Aguiar J, De La Rosa JV, et al. Phenalenone‐photodynamic therapy induces apoptosis on human tumor cells mediated by caspase‐8 and p38‐MAPK activation. Mol Carcinog. 2018;57:1525–1539.
   PubMed Web of Science ®Google Scholar
• Wang X, Gong Q, Song C, et al. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways. Toxicol Appl Pharmacol. 2021;418:115484.
   PubMed Web of Science ®Google Scholar
• Wang H, Xiong L, Xia Y, et al. 5-aminolaevulinic acid-based photodynamic therapy induces both necrosis and apoptosis of keratinocytes in plantar warts. J Cosmet Laser Ther. 2020;22:165–170.
   PubMed Web of Science ®Google Scholar
• Bin L, Xu G, Wang Z-Q, et al. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation. Acta Pharmacol Sin. 2017;38:1543–1553.
   PubMed Web of Science ®Google Scholar
• Inguscio V, Panzarini E, Dini L. Autophagy contributes to the death/survival balance in cancer photodynamic therapy. Cells. 2012;1:464–491.
   PubMedGoogle Scholar
• Mizuno-Yamasaki E, Rivera-Molina F, Novick P. GTPase networks in membrane traffic. Annu Rev Biochem. 2012;81:637–659.
   PubMed Web of Science ®Google Scholar
• Bueno MJ, De Castro IP, Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle. 2008;7:3143–3148.
   PubMed Web of Science ®Google Scholar
• Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature. 1991;349:117–127.
   PubMed Web of Science ®Google Scholar
• Li G, Zhang XC. GTP hydrolysis mechanism of Ras-like GTPases. J Mol Biol. 2004;340:921–932.
   PubMed Web of Science ®Google Scholar
• Tousley A, Iuliano M, Weisman E, et al. Rac1 activity is modulated by Huntingtin and dysregulated in models of Huntington’s disease. J Huntington’s Dis. 2019;8:53–69.
   PubMed Web of Science ®Google Scholar
• Villalonga P, Villalonga P, Ridley AJ. Rho GTPases and cell cycle control. Growth Factors. 2006;24:159–164.
   PubMed Web of Science ®Google Scholar
• Blanchard J. Small GTPases, adhesion, cell cycle control and proliferation. Pathologie-biologie. 2000;48:318–327.
   PubMedGoogle Scholar
• Ridley AJ. Rho GTPase signalling in cell migration. Curr Opin Cell Biol. 2015;36:103–112.
   PubMed Web of Science ®Google Scholar
• Govek -E-E, Newey SE, Van Aelst L. The role of the Rho GTPases in neuronal development. Genes Dev. 2005;19:1–49.
   PubMed Web of Science ®Google Scholar
• Stankiewicz TR, Linseman DA. Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration. Front Cell Neurosci. 2014;8:314.
   PubMed Web of Science ®Google Scholar
• DeGeer J, Lamarche-Vane N. Rho GTPases in neurodegeneration diseases. Exp Cell Res. 2013;319:2384–2394.
   PubMed Web of Science ®Google Scholar
• Kumar A, Al-Sammarraie N, DiPette DJ, et al. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma. Oncotarget. 2014;5:11709.
   PubMedGoogle Scholar
• Mokhtar SH, Kim MJ, Magee KA, et al. Amyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer’s disease. Neural Regen Res. 2018;13:1066.
   PubMed Web of Science ®Google Scholar
• Pozueta J, Lefort R, Ribe EM, et al. Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. Nat Commun. 2013;4:1–12.
   Web of Science ®Google Scholar
• Bolognin S, Lorenzetto E, Diana G, et al. The potential role of rho GTPases in Alzheimer’s disease pathogenesis. Mol Neurobiol. 2014;50:406–422.
   PubMed Web of Science ®Google Scholar
• Eftekharzadeh B, Daigle JG, Kapinos LE, et al. Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease. Neuron. 2018;99:925–40. e7.
   PubMed Web of Science ®Google Scholar
• Valencia A, Sapp E, Kimm JS, et al. Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington’s disease. Hum Mol Genet. 2013;22:1112.
   PubMed Web of Science ®Google Scholar
• Sanchez M, Gastaldi L, Remedi M, et al. Rotenone-induced toxicity is mediated by Rho-GTPases in hippocampal neurons. Toxicol Sci. 2008;104:352–361.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Dawson VL, Dawson TM. LRRK2 GTPase dysfunction in the pathogenesis of Parkinson’s disease. Biochem Soc Trans. 2012;40:1074–1079.
   PubMed Web of Science ®Google Scholar
• Wang S, Hu C, Wu F, et al. Rab25 GTPase: functional roles in cancer. Oncotarget. 2017;8:64591.
   PubMedGoogle Scholar
• Shaughnessy R, Echard A. Rab35 GTPase and cancer: linking membrane trafficking to tumorigenesis. Traffic. 2018;19:247–252.
   PubMed Web of Science ®Google Scholar
• Villagomez FR, Medina-Contreras O, Cerna-Cortes JF, et al. The role of the oncogenic Rab35 in cancer invasion, metastasis, and immune evasion, especially in leukemia. Small GTPases. 2020;11:334–345.
   PubMedGoogle Scholar
• Suzuki T, Tanaka M, Sasaki M, et al. Vascular shutdown by photodynamic therapy using talaporfin sodium. Cancers (Basel). 2020;12:2369.
   PubMed Web of Science ®Google Scholar
• Yousefi M, Koopaie M, Karimi R, et al. Effect of photodynamic therapy on expression of HRAS, NRAS and caspase 3 genes at mRNA levels, apoptosis of head and neck squamous cell carcinoma cell line. Photodiagnosis Photodyn Ther. 2021;33:102142.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Rhee Y, Chung P-S, et al. Sulforaphene enhances the efficacy of photodynamic therapy in anaplastic thyroid cancer through Ras/RAF/MEK/ERK pathway suppression. J Photochem Photobiol B Biol. 2018;179:46–53.
   PubMed Web of Science ®Google Scholar
• Kim S-M, Rhee Y-H, Kim J-S. The anticancer effects of radachlorin-mediated photodynamic therapy in the human endometrial adenocarcinoma cell line HEC-1-A. Anticancer Res. 2017;37:6251–6258.
   PubMed Web of Science ®Google Scholar
• Xu DD, Xu CB, Lam HM, et al. Proteomic analysis reveals that pheophorbide a-mediated photodynamic treatment inhibits prostate cancer growth by hampering GDP-GTP exchange of ras-family proteins. Photodiagnosis Photodyn Ther. 2018;23:35–39.
   PubMed Web of Science ®Google Scholar
• Pittet O, Petermann D, Michod D, et al. Effect of the TAT-RasGAP317–326 peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light. J Photochem Photobiol B Biol. 2007;88:29–35.
   PubMed Web of Science ®Google Scholar
• Wufuer R, Ma H-X, Luo M-Y, et al. Downregulation of Rac1/PAK1/LIMK1/cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy. Photodiagnosis Photodyn Ther. 2021;33:102143.
   PubMed Web of Science ®Google Scholar
• Ma H, Yang K, Li H, et al. Photodynamic effect of chlorin e6 on cytoskeleton protein of human colon cancer SW480 cells. Photodiagnosis Photodyn Ther. 2021;33:102201.
   PubMed Web of Science ®Google Scholar
• Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10:S10–S7.
   PubMed Web of Science ®Google Scholar
• Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science. 2002;296:1991–1995.
   PubMed Web of Science ®Google Scholar
• Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci. 2001;2:492–501.
   PubMed Web of Science ®Google Scholar
• Singleton A, Farrer M, Johnson J, et al. [alpha]-synuclein locus triplication causes Parkinson’s disease. Science. 2003;302:841–842.
   PubMed Web of Science ®Google Scholar
• Ashraf M,Greig N, Khan T, et al. Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus. CNS & Neurol Disord Drug Targets. 2014;13:1280–1293.
   PubMed Web of Science ®Google Scholar
• Lee BI, Chung YJ, Park CB. Photosensitizing materials and platforms for light-triggered modulation of Alzheimer’s β-amyloid self-assembly. Biomaterials. 2019;190:121–132.
   PubMed Web of Science ®Google Scholar
• Gao N, Sun H, Dong K, et al. Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer’s disease. Nat Commun. 2014;5:1–9.
   Web of Science ®Google Scholar
• Mangione M, Piccionello AP, Marino C, et al. Photo-inhibition of Aβ fibrillation mediated by a newly designed fluorinated oxadiazole. RSC Adv. 2015;5:16540–16548.
   Web of Science ®Google Scholar
• Ozawa D, Kaji Y, Yagi H, et al. Destruction of amyloid fibrils of keratoepithelin peptides by laser irradiation coupled with amyloid-specific thioflavin T. J Biol Chem. 2011;286:10856–10863.
   PubMed Web of Science ®Google Scholar
• Tsolekile N, Ncapayi V, Obiyenwa GK, et al. Synthesis of meso-tetra-(4-sulfonatophenyl) porphyrin (TPPS4)–CuInS/ZnS quantum dots conjugate as an improved photosensitizer. Int J Nanomedicine. 2019;14:7065.
   PubMed Web of Science ®Google Scholar
• Lee BI, Suh YS, Chung YJ, et al. Shedding light on Alzheimer’s β-amyloidosis: photosensitized methylene blue inhibits self-assembly of β-amyloid peptides and disintegrates their aggregates. Sci Rep. 2017;7:1–10.
   PubMed Web of Science ®Google Scholar
• Lee JS, Lee BI, Park CB. Photo-induced inhibition of Alzheimer’s β-amyloid aggregation in vitro by rose bengal. Biomaterials. 2015;38:43–49.
   PubMed Web of Science ®Google Scholar
• Dubey T, Gorantla NV, Chandrashekara KT, et al. Photoexcited toluidine blue inhibits Tau aggregation in Alzheimer’s disease. ACS Omega. 2019;4:18793–18802.
   PubMed Web of Science ®Google Scholar
• Dubey T, Gorantla NV, Chandrashekara KT, et al. Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells. Sci Rep. 2020;10:1–16.
   PubMed Web of Science ®Google Scholar
• Dubey T, Chinnathambi S. Brahmi (Bacopa monnieri): an ayurvedic herb against the Alzheimer’s disease. Arch Biochem Biophys. 2019;676:108153.
   PubMed Web of Science ®Google Scholar
• Dubey T, Chinnathambi S. Photodynamic sensitizers modulate cytoskeleton structural dynamics in neuronal cells. Cytoskeleton. 2021. DOI:10.1002/cm.21655
   PubMed Web of Science ®Google Scholar
• Wong HE, Kwon I. Xanthene food dye, as a modulator of Alzheimer’s disease amyloid-beta peptide aggregation and the associated impaired neuronal cell function. PLoS One. 2011;6:e25752.
   PubMed Web of Science ®Google Scholar
• Reinke AA, Gestwicki JE. Structure–activity Relationships of amyloid beta‐aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des. 2007;70:206–215.
   PubMed Web of Science ®Google Scholar
• Desale SE, Chinnathambi S. α-Linolenic acid induces clearance of Tau seeds via Actin-remodeling in Microglia. Mol Biomed. 2021;2:1–14.
   PubMedGoogle Scholar
• Desale SE, Chinnathambi S. Role of dietary fatty acids in microglial polarization in Alzheimer’s disease. J Neuroinflammation. 2020;17:1–14.
   PubMed Web of Science ®Google Scholar
• Das R, Balmik AA, Chinnathambi S. Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia. J Neuroinflammation. 2020;17:1–15.
   PubMed Web of Science ®Google Scholar
• Desale SE, Dubey T, Chinnathambi S. α-Linolenic acid inhibits Tau aggregation and modulates Tau conformation. Int J Biol Macromol. 2021;166:687–693.
   PubMed Web of Science ®Google Scholar
• Das R, Chinnathambi S. Microglial priming of antigen presentation and adaptive stimulation in Alzheimer’s disease. Cell Mol Life Sci. 2019;76:3681–3694.
   PubMed Web of Science ®Google Scholar
• Pocock JM, Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007;30:527–535.
   PubMed Web of Science ®Google Scholar
• Chidambaram H, Chinnathambi S. G-protein coupled receptors and tau-different roles in Alzheimer’s disease. Neuroscience. 2020;438:198–214.
   PubMed Web of Science ®Google Scholar
• Kettenmann H, Hanisch U-K, Noda M, et al. Physiology of microglia. Physiol Rev. 2011;91:461–553.
   PubMed Web of Science ®Google Scholar
• Reichhart V. Role of microglia in photodynamic therapy of glioma. 2018. Department of Biosciences Faculty of Natural Sciences Paris-Lodron-University Salzburg.
   Google Scholar
• Fisher CJ, Niu C, Foltz W, et al. ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia. PloS One. 2017;12:e0181654.
   PubMed Web of Science ®Google Scholar
• Kovaleva VD, Uzdensky AB. Photodynamic therapy-induced nitric oxide production in neuronal and glial cells. J Biomed Opt. 2016;21:105005.
   PubMed Web of Science ®Google Scholar
• Uzdensky A, Rudkovskii M, Fedorenko G, et al. Responses of crayfish neurons and glial cells to photodynamic impact: intracellular signaling, ultrastructural changes, and neuroglial interactions. Biochem (Moscow) Suppl Ser A. 2014;8:1–15.
   Google Scholar
• Komandirov M, Knyazeva E, Fedorenko Y, et al. Chemical modulation of photodynamic injury of glial cells. J Innovative Opt Health Sci. 2011;4:429–435.
   Web of Science ®Google Scholar
• Shibata S, Shinozaki N, Suganami A, et al. Photo-immune therapy with liposomally formulated phospholipid-conjugated indocyanine green induces specific antitumor responses with heat shock protein-70 expression in a glioblastoma model. Oncotarget. 2019;10:175.
   PubMedGoogle Scholar
• decarvalho AC, Zhang X, Roberts C, et al. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth. Glia. 2007;55:1053–1060.
   PubMed Web of Science ®Google Scholar
• Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. JNCI. 1993;85:443–456.
   PubMed Web of Science ®Google Scholar
• Grosjean P, Wagnieres G, Fontolliet C, et al. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer. 1998;77:1989–1995.
   PubMed Web of Science ®Google Scholar
• Mimura S, Ito Y, Nagayo T, et al. Cooperative clinical trial of photodynamic therapy with photofrin II and excimer dye laser for early gastric cancer. Lasers Surg Med. 1996;19:168–172.
   PubMed Web of Science ®Google Scholar
• Senge MO, Brandt JC. Temoporfin (Foscan®, 5, 10, 15, 20‐tetra (m‐hydroxyphenyl) chlorin)—a second‐generation photosensitizer. Photochem Photobiol. 2011;87:1240–1296.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Nitta M, Komori T, et al. Intraoperative photodynamic diagnosis using talaporfin sodium simultaneously applied for photodynamic therapy against malignant glioma: a prospective clinical study. Front Neurol. 2018;9:24.
   PubMed Web of Science ®Google Scholar
• Du K, Mick R, Busch T, et al. Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer. Lasers Surg Med. 2006;38:427–434.
   PubMed Web of Science ®Google Scholar
• Li X, Lovell JF, Yoon J, et al. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17:657–674.
   PubMed Web of Science ®Google Scholar
• Guo D, Xu S, Huang Y, et al. Platinum (IV) complex-based two-in-one polyprodrug for a combinatorial chemo-photodynamic therapy. Biomaterials. 2018;177:67–77.
   PubMed Web of Science ®Google Scholar
• Sun J-H, Zhang W, Zhang D-Y, et al. Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy. J Biomater Appl. 2018;32:1253–1264.
   PubMed Web of Science ®Google Scholar
• Choudhary S, Nouri K, Elsaie ML. Photodynamic therapy in dermatology: a review. Lasers Med Sci. 2009;24:971–980.
   PubMed Web of Science ®Google Scholar
• Sandberg C, Stenquist B, Rosdahl I, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2006;86:404–408.
   PubMed Web of Science ®Google Scholar